CION Ameerpet
Blurred vision, double vision, or losing part of your field of view is almost always a common, treatable eye problem. A brain tumour is a rare cause — but a few clear patterns are worth checking without delay.
If your eyesight has changed and you have found this page, take a breath. The overwhelming majority of blurred vision, double vision, and "something feels off" with the eyes comes from common, treatable problems — not a brain tumour. Brain tumour vision problems are real but uncommon, and they follow specific patterns we describe below.
The everyday causes of changing vision include:
The first and most useful step for almost anyone with a new vision change is a proper eye test with an optometrist or ophthalmologist. Many people leave with an updated prescription or eye drops and nothing more. If you want context on how vision fits into the wider picture, see our brain cancer and tumour hub.
A pituitary tumour sitting just below the brain can press on the optic chiasm — the crossover point of the two optic nerves — and classically causes loss of the outer half of vision in both eyes (bitemporal hemianopia). Because the loss creeps in from the sides, people often do not notice it until they bump into things or fail a driving field test. According to the clinical picture of pituitary adenoma described in NCCN and neuro-endocrine guidance, this pattern is a recognised prompt for a dedicated pituitary MRI.
A tumour does not "attack the eye". Instead, it affects vision in three main ways — by raising pressure inside the skull, by pressing on the visual pathways, or by disturbing the nerves that move the eyes. Knowing the mechanism helps you understand the warning patterns.
A tumour anywhere in the brain can raise pressure. This can cause brief episodes of dimming or greying vision, especially when standing up or straining, alongside a headache that is often worst in the morning. On examination, the optic nerve at the back of the eye may look swollen (papilloedema).
Tumours near the optic chiasm — such as a pituitary adenoma — press on the crossing optic nerves and cause loss of the outer fields in both eyes. Tumours in the occipital lobe at the back of the brain cause loss of the same half of the field in both eyes (hemianopia).
The nerves that move the eyes (the third, fourth, and sixth cranial nerves) can be affected by tumours near the brainstem or cavernous sinus. When one eye cannot move in step with the other, the result is double vision — two images side-by-side or one above the other — that persists when both eyes are open.
These situations are uncommon. But because early treatment protects sight, the patterns below are always worth checking. Talk to a CION specialist if any of them sound like you.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
If your eyesight has changed and you are worried, our neuro-oncology team will review your history, your eye report, and any imaging — and tell you clearly whether a brain MRI is needed.
A single symptom in isolation is rarely the whole story. What raises concern is a vision change that is new, persistent, and progressive — especially when it comes with headaches, nausea, or other neurological symptoms. Tap each pattern to understand why it matters and what to do.
The pathway is designed to answer two questions in order: is the problem in the eye, and if not, is there something behind the eyes that needs treatment?
An ophthalmologist or optometrist measures your vision, tests your visual fields, checks how the eyes move together, and looks into the back of the eye at the optic nerve. This step alone identifies and treats most causes — refractive error, cataract, dry eye, squint. It also picks up the findings that point beyond the eye: a field defect, an eye-movement (cranial-nerve) problem, or a swollen optic nerve.
If the eye examination suggests a cause behind the eyes, a brain MRI with gadolinium contrast is the gold-standard scan. It shows the optic pathways, the pituitary region, and any mass raising pressure inside the skull — with dedicated views of the pituitary and optic chiasm where needed. A CT scan is faster and used in emergencies, but MRI gives far more detail of the visual pathway. You can read more about how imaging leads into full brain tumour treatment in Hyderabad.
If a tumour is found, CION's neuro-oncology tumour board reviews every case together — so you get one coordinated plan, not fragmented advice. We deliver directly: radiation therapy (IMRT/IGRT), medical and systemic therapy, molecular testing, and steroid and swelling management. Any neurosurgery — for example removing a pituitary tumour through the nose — is coordinated with our accredited neurosurgical partners. The shared goal across every specialty is to relieve pressure on the visual pathway early and protect the sight you have.
When a tumour compresses the optic pathway, how much vision recovers after treatment depends heavily on how early the pressure is relieved. NCCN and neuro-oncology guidance emphasise timely imaging and multidisciplinary review precisely because visual outcomes are time-sensitive — a good reason not to postpone assessment of a persistent, progressive vision change.
Remember: a vision change is far more likely to be an eye problem than a brain tumour. Getting it checked is not overreacting — it is the fastest way to reassurance, or to early treatment if it is ever needed. Explore related warning signs on our brain cancer and tumour hub, or read about the brain tumour headache pattern.
Get a Free Second Opinion or call 18002028726.
A free, unhurried 45-minute consultation with CION's neuro-oncology team — we'll review your eye report or MRI and tell you exactly what, if anything, comes next.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Yes, but it is an uncommon cause. Most blurred or double vision comes from everyday problems — an out-of-date glasses prescription, dry eye, cataract, migraine, or tiredness. A tumour can affect vision when it raises pressure inside the skull or presses on the visual pathways or the nerves that move the eyes. The key difference is the pattern: tumour-related vision change is usually new, persistent, and slowly worsening — and often comes with other clues such as morning headaches, nausea, or one-sided weakness. An eye test and, if needed, a brain MRI can tell the two apart.
The most concerning patterns are: losing the same half of your field of view in both eyes (a hemianopia — you keep bumping into door frames or missing words on one side of the page); sudden new double vision that does not go away when you cover one eye; and vision that dims when you stand or bear down, often with a worsening morning headache. Any of these, especially if they are new, persistent, and getting worse, deserves prompt assessment. They are far more often caused by non-tumour conditions, but the pattern should never be ignored.
Tumours near the visual pathway matter most. A pituitary adenoma can press on the optic chiasm, classically causing loss of the outer (peripheral) fields in both eyes. Tumours in the occipital lobe at the back of the brain can cause loss of one side of the visual field. Any tumour that raises pressure inside the skull can blur vision and cause swelling of the optic nerve (papilloedema). Tumours near the brainstem or cavernous sinus can affect the nerves that move the eyes, producing double vision.
Start with a proper eye examination. An ophthalmologist or optometrist can measure your vision, check eye movements, and look at the optic nerve at the back of the eye. Many causes — squint, dry eye, refractive error — are found and treated there. If the eye exam finds swelling of the optic nerve, a field defect, an eye-movement (cranial-nerve) problem, or if double vision is sudden with headache, imaging is the next step. A brain MRI with contrast is the test that shows a tumour. CION coordinates the scan and reviews it the same week.
Papilloedema is swelling of the optic nerve head, seen when a doctor looks into the back of the eye. It is a sign of raised pressure inside the skull, which a tumour can cause. Early on it may cause brief episodes of dimming vision, especially when standing or straining, along with headache. Because papilloedema points to raised intracranial pressure, it is treated as an urgent finding — prompting brain imaging to find the cause. It is one of the reasons a dilated eye examination is such a useful step when vision changes are unexplained.
Diagnosis begins with a clinical and eye assessment, then a brain MRI with gadolinium contrast — the gold-standard scan — often with dedicated views of the pituitary and optic pathways. If a tumour is found, CION's neuro-oncology tumour board reviews every case. We deliver directly: radiation therapy (IMRT/IGRT), medical and systemic therapy, imaging, molecular testing, and steroid and swelling management. Any neurosurgery — such as removing a pituitary tumour through the nose — is coordinated with our accredited neurosurgical partners. Every plan is built around protecting your remaining vision.
It depends on how long the visual pathway was compressed and how much damage occurred. When a tumour such as a pituitary adenoma is relieved early, vision often improves — sometimes substantially. Long-standing compression may leave permanent field loss. Double vision from an eye-movement nerve can recover as swelling settles or the tumour is treated. This is exactly why early assessment matters: the sooner the pressure on the visual pathway is relieved, the better the chance of recovering sight. Your CION team will give you a realistic, individual picture.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist or ophthalmologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines from bodies such as NCCN and EANO.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.